Challenges in interpreting SARS-CoV-2 serological results in African countries

Affiliations

¹ Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Institut de Recherche pour le Développement, University of Montpellier, Montpellier, France.
² Tropical Infectious Diseases Unit, Department of Public Health, 2000 Antwerp, Belgium; Institute of Tropical Medicine, 2000 Antwerp, Belgium. Electronic address: ahoxha@itg.be.
³ Department of Epidemiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
⁴ Virology Unit, Department of Biomedical Sciences, 2000 Antwerp, Belgium; Evolutionary Ecology Group, University of Antwerp, Antwerp, Belgium.
⁵ Institut de Recherche pour le Développement, University of Montpellier, Montpellier, France.
⁶ Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.
⁷ Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Microbiology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
⁸ Virology Unit, Department of Biomedical Sciences, 2000 Antwerp, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
⁹ Department of Epidemiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Microbiology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
¹⁰ Tropical Infectious Diseases Unit, Department of Public Health, 2000 Antwerp, Belgium.

PMID: 33609481
PMCID: PMC7906714
DOI: 10.1016/S2214-109X(21)00060-7

Challenges in interpreting SARS-CoV-2 serological results in African countries

Antoine Nkuba Ndaye et al. Lancet Glob Health. 2021 May.

. 2021 May;9(5):e588-e589.

doi: 10.1016/S2214-109X(21)00060-7. Epub 2021 Feb 17.

Affiliations

¹ Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Institut de Recherche pour le Développement, University of Montpellier, Montpellier, France.
² Tropical Infectious Diseases Unit, Department of Public Health, 2000 Antwerp, Belgium; Institute of Tropical Medicine, 2000 Antwerp, Belgium. Electronic address: ahoxha@itg.be.
³ Department of Epidemiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
⁴ Virology Unit, Department of Biomedical Sciences, 2000 Antwerp, Belgium; Evolutionary Ecology Group, University of Antwerp, Antwerp, Belgium.
⁵ Institut de Recherche pour le Développement, University of Montpellier, Montpellier, France.
⁶ Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.
⁷ Department of Virology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Microbiology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
⁸ Virology Unit, Department of Biomedical Sciences, 2000 Antwerp, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
⁹ Department of Epidemiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Microbiology, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
¹⁰ Tropical Infectious Diseases Unit, Department of Public Health, 2000 Antwerp, Belgium.

PMID: 33609481
PMCID: PMC7906714
DOI: 10.1016/S2214-109X(21)00060-7

Erratum in

Correction to Lancet Glob Health 2021; published online Feb 17. https://doi.org/10.1016/S2214-109X(21)00060-7.
[No authors listed] [No authors listed] Lancet Glob Health. 2021 May;9(5):e597. doi: 10.1016/S2214-109X(21)00142-X. Epub 2021 Mar 8. Lancet Glob Health. 2021. PMID: 33705689 Free PMC article. No abstract available.

No abstract available

PubMed Disclaimer

References

1. Montesinos I, Gruson D, Kabamba B, et al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol. 2020;128 - PMC - PubMed
1. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012;22:276–282. - PMC - PubMed
1. Olayanju O, Bamidele O, Edem F, et al. SARS-CoV-2 seropositivity in asymptomatic frontline health workers in Ibadan, Nigeria. Am J Trop Med Hyg. 2021;104:91–94. - PMC - PubMed
1. Hsiao M, Davies M-A, Kalk E, et al. National Institute for Communicable Diseases; Sept 28, 2020. SARS-CoV-2 seroprevalence in the Cape Town metropolitan sub-districts after the peak of infections.https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Publi...
1. Chibwana MG, Jere KC, Kamng'ona R, et al. High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi [version 2; peer review: 2 approved] Wellcome Open Res. 2020;5:199.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Challenges in interpreting SARS-CoV-2 serological results in African countries

Affiliations

Challenges in interpreting SARS-CoV-2 serological results in African countries

Authors

Affiliations

Erratum in

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous